Clinical Trial Results: Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD. [Phase 2]

View source ↗

Summary

Phase 2 trial results for intramuscular PDA-002 in subjects with diabetic foot ulcers, with and without peripheral arterial disease, terminated with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot
• Peripheral Arterial Disease

Drugs mentioned

• PDA-002

Snippet

Sponsor: Celularity Incorporated | Conditions: Peripheral Arterial Disease, Diabetic Foot | Phase 2 | Status: TERMINATED | Results posted: 2026-06-12